Under the partnership, Catalent has ordered visual inspection machines from Stevanato Group to install at its Bloomington, IN and Anagni, Italy facilities to support customer programs.
Catalent and Stevanato Group, an producer of glass primary packaging and integrated systems headquartered in Italy, announced on Oct. 27, 2020 that they are expanding their longstanding collaboration to accelerate the delivery of advanced visual inspection systems to help with potential solutions for the COVID-19 pandemic.
Under the partnership, Catalent has ordered Plus 400 LKD automatic and PWL semi-automatic visual inspection machines from Stevanato Group to install at its Bloomington, IN, and Anagni, Italy facilities to support customer programs, a Stevanato press release said. Stevanato will accelerate the delivery of the equipment by several months to meet the demands of the pandemic.
“Catalent appreciates Stevanato Group’s commitment to delivering these vital inspection machines to our sites ahead of schedule,” said Dominick Marino, vice-president of Global Procurement at Catalent, in the press release. “This added capability will increase the speed in which we package and supply important medicines for our customers and patients.”
“We understand what is at stake, and our engineers are committed to delivering high-performance inspection machines ahead of schedule to meet Catalent’s needs and expectations,” added Raffaele Pace, engineering vice-president of Operations, Stevanato Group, in the press release.
Source: Stevanato Group
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.